Identification of Prominent Genes Between 3D Glioblastoma Models and Clinical Samples Via GEO/TCGA/CGGA Data Analysis

Overview

Journal Biology (Basel)

Publisher MDPI

Specialty Biology

Date 2023 May 27

PMID 37237462

Authors

Brandon Wee Siang Phon

Saatheeyavaane Bhuvanendran

Qasim Ayub

Ammu Kutty Radhakrishnan

Muhamad Noor Alfarizal Kamarudin

Affiliations

Soon will be listed here.

Abstract

A paradigm shift in preclinical evaluations of new anticancer GBM drugs should occur in favour of 3D cultures. This study leveraged the vast genomic data banks to investigate the suitability of 3D cultures as cell-based models for GBM. We hypothesised that correlating genes that are highly upregulated in 3D GBM models will have an impact in GBM patients, which will support 3D cultures as more reliable preclinical models for GBM. Using clinical samples of brain tissue from healthy individuals and GBM patients from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), Chinese Glioma Genome Atlas (CGGA), and Genotype-Tissue Expression (GTEx) databases, several genes related to pathways such as epithelial-to-mesenchymal transition (EMT)-related genes (, , , , , ), angiogenesis/migration-related genes (, , , ), hypoxia-related genes (, ), stemness-related genes (, , , ), and genes involved in the Wnt signalling pathway (, ) were found to be upregulated in brain samples from GBM patients, and the expression of these genes were also enhanced in 3D GBM cells. Additionally, EMT-related genes were upregulated in GBM archetypes (wild-type ) that historically have poorer treatment responses, with said genes being significant predictors of poorer survival in the TCGA cohort. These findings reinforced the hypothesis that 3D GBM cultures can be used as reliable models to study increased epithelial-to-mesenchymal transitions in clinical GBM samples.

References

Liang H, Chen G, Li J, Yang F . Snail expression contributes to temozolomide resistance in glioblastoma. Am J Transl Res. 2019; 11(7):4277-4289. PMC: 6684932. View

Tompa M, Kalovits F, Nagy A, Kalman B . Contribution of the Wnt Pathway to Defining Biology of Glioblastoma. Neuromolecular Med. 2018; 20(4):437-451. DOI: 10.1007/s12017-018-8514-x. View

Labussiere M, Sanson M, Idbaih A, Delattre J . IDH1 gene mutations: a new paradigm in glioma prognosis and therapy?. Oncologist. 2010; 15(2):196-9. PMC: 3227941. DOI: 10.1634/theoncologist.2009-0218. View

Zhang K, Liu X, Li G, Chang X, Li S, Chen J . Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA. Cancer Biol Med. 2022; 19(10). PMC: 9630520. DOI: 10.20892/j.issn.2095-3941.2022.0469. View

Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

Myung J, Choi S, Kim S, Wang K, Park S . Snail plays an oncogenic role in glioblastoma by promoting epithelial mesenchymal transition. Int J Clin Exp Pathol. 2014; 7(5):1977-87. PMC: 4069885. View

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View

Murphy G, Nagase H . Progress in matrix metalloproteinase research. Mol Aspects Med. 2008; 29(5):290-308. PMC: 2810947. DOI: 10.1016/j.mam.2008.05.002. View

Breslin S, ODriscoll L . Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today. 2012; 18(5-6):240-9. DOI: 10.1016/j.drudis.2012.10.003. View

10.

Hwang T, Kim S, Chowdhury T, Yu H, Kim K, Kang H . Genome-wide perturbations of Alu expression and Alu-associated post-transcriptional regulations distinguish oligodendroglioma from other gliomas. Commun Biol. 2022; 5(1):62. PMC: 8766575. DOI: 10.1038/s42003-022-03011-w. View

11.

Ostrom Q, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan J . CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018. Neuro Oncol. 2021; 23(12 Suppl 2):iii1-iii105. PMC: 8491279. DOI: 10.1093/neuonc/noab200. View

12.

Cooper L, Gutman D, Chisolm C, Appin C, Kong J, Rong Y . The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. Am J Pathol. 2012; 180(5):2108-19. PMC: 3354586. DOI: 10.1016/j.ajpath.2012.01.040. View

13.

Kapalczynska M, Kolenda T, Przybyla W, Zajaczkowska M, Teresiak A, Filas V . 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Arch Med Sci. 2018; 14(4):910-919. PMC: 6040128. DOI: 10.5114/aoms.2016.63743. View

14.

Zhang K, Wang X, Zhou B, Zhang L . The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis. Fam Cancer. 2013; 12(3):449-58. DOI: 10.1007/s10689-013-9607-1. View

15.

Ross D, Scherf U, Eisen M, Perou C, Rees C, Spellman P . Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet. 2000; 24(3):227-35. DOI: 10.1038/73432. View

16.

Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z . clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021; 2(3):100141. PMC: 8454663. DOI: 10.1016/j.xinn.2021.100141. View

17.

Gomez-Oliva R, Dominguez-Garcia S, Carrascal L, Abalos-Martinez J, Pardillo-Diaz R, Verastegui C . Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments. Front Oncol. 2021; 10:614295. PMC: 7878535. DOI: 10.3389/fonc.2020.614295. View

18.

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View

19.

Pankov R, Yamada K . Fibronectin at a glance. J Cell Sci. 2002; 115(Pt 20):3861-3. DOI: 10.1242/jcs.00059. View

20.

Xu L, Chen Y, Huang Y, Sandanaraj E, Yu J, Lin R . Topography of transcriptionally active chromatin in glioblastoma. Sci Adv. 2021; 7(18). PMC: 8087410. DOI: 10.1126/sciadv.abd4676. View